Newly refined antibody therapy may be potent treatment for autoimmune diseases

Apr 28, 2008

An old, fickle therapy for a variety of autoimmune diseases is getting a makeover, thanks to a decade-long investigation by Rockefeller University researchers. The original treatment, called intravenous immunoglobulin or IVIG, is an amalgam of specific antibodies made from the pooled blood plasma of thousands of healthy donors.

Physicians have used it both on-label and off in patients with lupus, arthritis, asthma and other immune disorders, to varying degrees of success. But new research shows that understanding how the therapy works at a molecular level can help researchers create a version in the lab that’s many times more potent.

Jeffrey Ravetch, Theresa and Eugene M. Lang Professor and head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology, has been interested in IVIG ever since he became aware of its inherent paradox: IgG antibodies, the very class of antibodies that triggers autoimmune diseases, give IVIG its anti-inflammatory properties when pooled from healthy donors.

In 2006, Ravetch and his colleagues discovered that this apparent contradiction could be attributed to a single sugar molecule called sialic acid, located at the very tip of some IgG antibodies. When present, the molecule confers anti-inflammatory properties. When absent, the IgG molecules lose their protective abilities and can actually cause inflammation.

Once the scientists had pinned down the molecular mechanism at the source of the contradiction and proved that they could map out a strategy for building a drug with the therapeutic properties of IVIG, they set about creating it. Ravetch, together with his collaborators at the University of New Hampshire and The Scripps Research Institute, produced an engineered, sialylated IgG molecule that — when given to arthritic mice — was about 30 times more effective than IVIG alone.

“This paper provides a clear route for developing an alternative for IVIG, which could be of great benefit to patients with autoimmune diseases,” Ravetch says. The results, reported in the latest issue of Science, also describe the precise structural requirements needed to create IgG with protective properties.

Rockefeller has licensed the technology to the biotechnology company Centaurus Pharmaceuticals, which is working to create a product that can be used in clinical trials. Ravetch believes that the resulting drug will have the potential to provide relief to people with a wide range of ailments, including those for whom IVIG just barely scratches the surface. In lupus, for instance, the current preparation has such low activity that the amount required to effect a noticeable difference exceeds the amount that can be realistically derived from the blood supply. “But with the recombinant form,” Ravetch says, “you can make an unlimited, potent supply.”

Citation: Science 320 (5874): 373–376 (April 18, 2008)

Source: Rockefeller University

Explore further: Leeches help save woman's ear after pit bull mauling

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Leeches help save woman's ear after pit bull mauling

12 minutes ago

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

New pain relief targets discovered

11 hours ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

12 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

User comments : 0

More news stories

Leeches help save woman's ear after pit bull mauling

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

Scientists tether lionfish to Cayman reefs

Research done by U.S. scientists in the Cayman Islands suggests that native predators can be trained to gobble up invasive lionfish that colonize regional reefs and voraciously prey on juvenile marine creatures.

Venture investments jump to $9.5B in 1Q

Funding for U.S. startup companies soared 57 percent in the first quarter to a level not seen since 2001, as venture capitalists piled more money into an increasing number of deals, according to a report due out Friday.

White House updating online privacy policy

A new Obama administration privacy policy out Friday explains how the government will gather the user data of online visitors to WhiteHouse.gov, mobile apps and social media sites. It also clarifies that ...